The events are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling addresses: "based on information reported to fda and found in medical literature, a possible association has been identified between breast implants and the rare development of anaplastic large cell lymphoma (alcl), a type of non-hodgkin¿s lymphoma.Women with breast implants may have a very small but increased risk of developing alcl in the fluid or scar capsule adjacent to the implant.Alcl has been reported globally in patients with an implant history that includes allergan¿s and other manufacturers¿ breast implants.You should consider the possibility of alcl when you have a patient with late onset, persistent peri-implant seroma.In some cases, patients presented with capsular contracture or masses adjacent to the breast implant.When testing for alcl, collect fresh seroma fluid and representative portions of the capsule, and send for pathology tests to rule out alcl.If your patient is diagnosed with peri-implant alcl, develop an individualized treatment plan in coordination with a multi-disciplinary care team.Because of the small number of cases worldwide, there is no defined consensus treatment regimen for peri-implant alcl.Potential adverse events that may occur with breast implant surgery include:.Reoperation, implant removal, infection." 'bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma¿ 137, 6, (1659-1669) by honghua hu, ph.D.; khalid johani; ahmad almatroudi; karen vickery, ph.D., b.V.Sc.; bruce van natta, m.D.; marshall e.Kadin, m.D.; garry brody, m.D.; mark clemens, m.D.; chan yoon cheah, m.D.; stephen lade, m.D.; preeti avinash joshi, m.D.,ph.D.; h.Miles prince, m.D.,ph.D.; anand k.Deva, b.Sc.(med.), m.B.B.S., m.S.Published june 2016.
|
Literature article ¿bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma¿ reports ¿twenty-six breast implant¿associated alcl samples were gathered from four centers for this international collaborative study from a total of 22 patients (table 1).¿ article goes on to state: ¿both the breast implant¿associated alcl and nontumor capsule samples yielded high mean numbers of bacteria (breast implant¿associated alcl, 4.7 × 106 cells/mg of tissue; capsule, 4.9 × 106 cells/mg of tissue).Analysis of the microbiome in breast implant¿associated alcl specimens showed significant differences with species identified in nontumor capsule specimens.There was a significantly greater proportion of ralstonia spp.Present in alcl specimens compared with nontumor capsule specimens (p < 0.05).In contrast, significantly more staphylococcus spp.Were found associated with nontumor capsule specimens compared with breast implant¿associated alcl specimens (p < 0.001).Bacterial biofilm was visualized both on scanning electron microscopy and fluorescent in situ hybridization.¿ cytological markers alk- and cd30+ have been reported.According to table 1 ¿clinical summary of breast implant¿associated alcl patients,¿ there were 3 cases of alcl where the presentation is ¿not known.¿ there is currently no way to determine which cases had which device type or tested negative for bacterial infection.This report will capture 3 cases of alcl where the presentation is ¿not known.¿.
|